Raid Parkinson’s Disease Lawsuit Overview

Raid Parkinson’s disease lawsuit investigations allege that manufacturers failed to adequately test chlorpyrifos-containing household insecticides for long-term neurological side effects and failed to warn consumers about the risks associated with repeated exposure.

Certain older Raid formulations were sold for routine household pest control, creating a very different exposure pattern than chlorpyrifos products used mainly in agricultural settings. Consumers may have sprayed these products repeatedly inside homes, apartments and other occupied buildings over months or years, often without any reason to suspect that long-term use could affect the nervous system.

Historical Raid products containing chlorpyrifos were marketed for uses that included:

• Roach control in homes and apartments
• Flea treatment in residential living areas
• Ant and crawling insect control
• Whole-home insect treatment
• Recurring infestation control
• Residual pest control intended to continue working after application

Similar exposure may have occurred among individuals who used other popular residential pesticides that also contained chlorpyrifos, including Dursban, Ortho Home Pest Insect Control, Ortho-Klor and other household pest-control products.

In addition to claims involving Raid and other household products, chlorpyrifos Parkinson’s disease lawsuits are also being pursued for other exposure settings, including agricultural applications of commercial products like Lorsban and pesticide exposure for Gulf War veterans during military operations in the Persian Gulf region from 1990 through 1991, when chlorpyrifos was widely around living quarters, work areas and other military facilities for pest control.

Raid Parkinson’s Disease Risk

Certain older Raid insecticides were formulated with chlorpyrifos, a broad-spectrum organophosphate pesticide designed to interfere with the nervous systems of insects.

Chlorpyrifos works by inhibiting acetylcholinesterase, an enzyme that helps regulate nerve signaling. While that mechanism makes the pesticide effective against insects, researchers have also raised concerns about the neurological effects of repeated or long-term human exposure.

Those concerns have become particularly important for individuals who regularly used older chlorpyrifos-containing Raid sprays inside homes, apartments and other enclosed spaces.

A study published in Molecular Neurodegeneration evaluated 829 individuals with Parkinson’s disease and 824 individuals without the condition, using residential and workplace locations together with historical pesticide application data to estimate chlorpyrifos exposure. Researchers found that:

• Individuals with substantial long-term residential chlorpyrifos exposure faced more than a 2.5-fold increased risk of developing Parkinson’s disease.
• The study also found neurological changes in mice exposed to aerosolized chlorpyrifos, including motor impairment, loss of dopamine-producing neurons, brain inflammation and accumulation of pathological alpha-synuclein.

Those findings are particularly relevant to potential Raid lawsuits because certain older formulations were intended for repeated household pest control, potentially exposing users to chlorpyrifos over extended periods of time.

How Chlorpyrifos Causes Parkinson’s Disease?

Parkinson’s disease develops as dopamine-producing neurons in the brain become damaged or die, disrupting the signals that control movement and coordination. Researchers believe chlorpyrifos exposure may contribute to that process through several neurological mechanisms, including:

• Dopamine neuron loss: Chlorpyrifos exposure has been associated with damage to dopamine-producing neurons that are progressively lost in Parkinson’s disease.
• Alpha-synuclein accumulation: Researchers found increased pathological alpha-synuclein, a protein that can form abnormal deposits in the brains of individuals with Parkinson’s disease.
• Neuroinflammation: Chlorpyrifos may activate inflammatory cells in the brain, potentially contributing to ongoing neurological damage.
• Impaired autophagy: Research suggests chlorpyrifos may interfere with the cellular process used to remove damaged proteins and other waste.
• Oxidative stress and mitochondrial dysfunction: Chlorpyrifos exposure has also been linked in laboratory research to cellular stress and impaired mitochondrial function, which may make dopamine-producing neurons more vulnerable to injury.
• Motor impairment: Experimental exposure has produced movement and coordination problems consistent with damage to neurological pathways involved in Parkinson’s disease.

These mechanisms do not establish that every person exposed to chlorpyrifos will develop Parkinson’s disease. However, the combination of epidemiological findings and laboratory evidence has strengthened concerns that repeated exposure may contribute to the development of the condition.

Which Raid Products Contained Chlorpyrifos?

Prior to the year 2000, several older Raid products were formulated with chlorpyrifos, although the ingredient was not used across the entire Raid line. For a potential Parkinson’s disease claim, identifying the exact product and years of use is important because Raid formulations changed over time. Documented chlorpyrifos-containing products include:

Raid Formula 32 Insect Spray

Raid Formula 32 was marketed as a whole-home treatment for roaches, fleas and other household insects, with residual activity intended to continue killing pests after application.

A 1989 EPA-approved label for Raid Formula 32 lists chlorpyrifos at 0.50% and directs users to apply the spray around baseboards, cabinets, appliances, plumbing areas, carpets and other locations where insects were likely to hide or travel.

Raid Formula 34 Insect Spray

Raid Formula 34 was another household insect spray sold during the same general period, but it used a different combination of active ingredients.

Its 1989 EPA-approved label identifies chlorpyrifos as an active ingredient in the formulation, along with other insecticidal compounds used for residential pest control.

Raid Home Insect Killer Formula II

Raid Home Insect Killer Formula II was marketed for use in and around the home against roaches, fleas, ants and other common pests, with residual insect control designed to continue after the initial treatment.

A 1991 EPA-approved label for Raid Home Insect Killer Formula II lists chlorpyrifos at 0.50% under EPA Registration No. 4822-238.

Raid Treatment for Crawling Insects

Raid Treatment for Crawling Insects was designed specifically for roaches and other pests that hide in cracks, crevices and other tight indoor spaces.

A 1998 EPA-approved label lists chlorpyrifos at 0.50% and directs users to apply the product beneath baseboards, behind refrigerators and washing machines, beneath sinks, between cabinets and under counters.

These products were sold during a period when chlorpyrifos was still widely permitted for residential pest control. That changed in 2000, when the EPA announced an agreement to eliminate nearly all residential uses of chlorpyrifos after concluding that indoor and post-application exposures could pose unacceptable risks, particularly to children. Most homeowner uses were subsequently canceled, and the EPA now states that there are no residential uses of chlorpyrifos.

For a potential Raid Parkinson’s disease claim, that history makes the specific product, years of use and frequency of exposure especially important when determining whether an individual was exposed to a chlorpyrifos-containing formulation.

How Were People Exposed to Chlorpyrifos in Raid?

Raid was different from many agricultural chlorpyrifos products because exposure often occurred inside the home, where consumers may have sprayed the pesticide repeatedly over months or years.

Someone treating a persistent roach or flea problem may have applied the product in kitchens, bathrooms, basements, bedrooms or other enclosed spaces, sometimes returning to the same locations whenever insects reappeared.

Depending on the product and how it was used, chlorpyrifos exposure from the use of certain Raid products may have occurred through:

• Breathing spray mist while applying Raid indoors
• Skin contact while holding, spraying or cleaning up the pesticide
• Repeated applications for ongoing roach, flea or ant infestations
• Indoor spraying in kitchens, bathrooms, basements, garages and other enclosed spaces
• Residual exposure from treated carpets, floors, baseboards and other surfaces
• Workplace exposure among maintenance, property-management and pest-control workers
• Secondary exposure from spending substantial time in repeatedly treated rooms or buildings

For a potential lawsuit, the frequency and duration of that exposure may be just as important as the product itself. Someone who repeatedly treated an infestation for years may have a very different exposure history than someone who used an insecticide only occasionally.

Parkinson’s Disease Symptoms After Raid Exposure

Although most residential chlorpyrifos uses were phased out beginning in 2000, Parkinson’s disease may not be diagnosed until many years after the exposure occurred. Early symptoms can also be subtle, progressing gradually before problems with movement and coordination become more obvious.

Common Parkinson’s Disease Symptoms

• Tremors or shaking
• Slowed movement
• Muscle stiffness
• Difficulty walking
• Balance problems
• Changes in posture
• Reduced facial expression
• Smaller handwriting
• Speech changes
• Loss of smell
• Sleep problems

Individuals diagnosed with Parkinson’s disease who repeatedly used older Raid products should try to identify when the products were used, what insects they were treating and whether they remember a particular Raid formulation.

How Do You Prove Raid Chlorpyrifos Exposure?

Proving exposure may be one of the most important parts of a Raid Parkinson’s disease claim, especially since many individuals used these products decades ago and no longer have the original container.

Our lawyers may look at several types of information to determine whether a particular Raid product contained chlorpyrifos, including:

• Approximate years of use
• Specific Raid product names or packaging
• Whether the product was an aerosol, liquid or crack-and-crevice spray
• What insects were being treated
• How often the product was used
• Where the pesticide was applied
• Whether the exposure occurred at home or through work
• Old photographs, receipts or containers
• Statements from family members or coworkers who remember the product

Historical EPA product labels and registration records can then be compared with that information to determine whether chlorpyrifos was an active ingredient during the relevant period.

The more detail an individual can provide about the product, timeframe, frequency and location of use, the easier it may be to reconstruct a history of chlorpyrifos exposure.

Raid Lawsuit Allegations

Raid Parkinson’s disease lawsuits may allege that companies responsible for chlorpyrifos-containing Raid products failed to adequately evaluate and warn about the long-term neurological risks of repeated residential exposure.

Depending on the product and exposure history involved, potential claims may allege that manufacturers:

• Failed to adequately study the effects of repeated household chlorpyrifos exposure
• Failed to investigate whether long-term exposure could increase the risk of Parkinson’s disease
• Sold residential insecticides that were unreasonably dangerous when used as intended
• Failed to warn about the potential for permanent neurological injury
• Downplayed or failed to adequately disclose evidence of chlorpyrifos neurotoxicity
• Marketed chlorpyrifos-containing Raid products for repeated use inside homes and other occupied buildings
• Failed to provide adequate instructions for reducing chronic exposure
• Relied on safety testing that did not fully address long-term neurological risks
• Focused product warnings on acute poisoning rather than diseases that may develop years later
• Continued selling chlorpyrifos-containing household insecticides without adequate warnings about Parkinson’s disease risk

Potential lawsuits may argue that those warnings did not adequately inform homeowners, renters, maintenance workers and others that repeated use of chlorpyrifos-containing Raid products could contribute to neurological disease years after the exposure occurred.

Each claim will depend on the specific Raid formulation, years and frequency of use, circumstances of exposure, Parkinson’s disease diagnosis and other evidence showing that the individual was exposed to chlorpyrifos.

Compensation From a Raid Parkinson’s Disease Lawsuit

Parkinson’s disease can affect nearly every part of daily life, including mobility, independence, employment and the ability to perform routine activities without assistance.

Individuals who establish that their Parkinson’s disease was caused by exposure to a chlorpyrifos-containing Raid product may be entitled to financial compensation for losses such as:

• Medical expenses
• Future medical treatment
• Parkinson’s disease medications
• Physical and occupational therapy
• Lost wages
• Reduced earning capacity
• Pain and suffering
• Permanent disability
• Loss of independence
• Home assistance or long-term care needs

The value of a Raid Parkinson’s disease lawsuit will depend on the individual’s exposure history, diagnosis, severity of the condition, financial losses and other case-specific factors.

Contact a Raid Parkinson’s Disease Lawyer

If you or a loved one developed Parkinson’s disease after years of using older Raid insecticides, Saiontz & Kirk can help determine whether the products involved contained chlorpyrifos and whether the exposure history may support a claim.

Our lawyers can review the product name, approximate years of use, frequency of exposure and historical pesticide records to help determine whether a qualifying chlorpyrifos-containing Raid formulation was involved.

There are no upfront costs to obtain a case evaluation or hire our lawyers. All cases are handled on a contingency fee basis, which means attorney fees and expenses are only paid if a settlement or recovery is obtained.

Call 1-800-522-0102 or complete the form to speak with a Raid Parkinson’s disease lawyer.

FIND OUT IF YOU QUALIFY FOR A RAID LAWSUIT